Scottish patient becomes Europe’s first to receive individualised neoantigen therapy for gastro-oesophageal cancer

Jennifer Robertson. Credit: University of Dundee/PA Wire

By Ella Pickover, PA Media

A woman from Scotland has become the first patient in Europe to receive a personalised cancer vaccine for gastro-oesophageal cancer.

Jennifer Robertson said that she is “excited and privileged” to be on the early-stage clinical trial for the vaccine.